• Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

RCUS:BB

40.3500 EUR 0.2750 0.69%

As of 11:35:00 ET on 09/19/2014.

Snapshot for Arseus NV (RCUS)

Open: 40.2750 Day's Range: 40.0800 - 40.9650 Volume: 38,654
Previous Close: 40.0750 52wk Range: 20.4500 - 44.9800 1-Yr Rtn: +87.86%

Stock Chart for RCUS

No chart data available.
  • RCUS:BB 40.3500
  • 1D
  • 1M
  • 1Y
40.0750
Interactive RCUS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RCUS

Current P/E Ratio (ttm) 24.9689
Estimated P/E(12/2014) 20.4200
Relative P/E vs. BEL20 0.5030
Earnings Per Share (EUR) (ttm) 1.6160
Est. EPS (EUR) (12/2014) 1.9760
Est. PEG Ratio -
Market Cap (M EUR) 1,268.26
Shares Outstanding (M) 31.43
30 Day Average Volume 52,491
Price/Book (mrq) 8.4302
Price/Sale (ttm) 3.9527
Dividend Indicated Gross Yield 1.78%
Cash Dividend (EUR) 0.5400
Dividend Ex-Date 05/14/2014
5 Year Dividend Growth 19.14%
Next Earnings Announcement 03/03/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RCUS

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for RCUS

Arseus NV provides a wide range of products for the health, wellness, esthetics and ageing populations. The Company distributes and resells dental equipment, medical equipment, pharmaceuticals, and provides integrated information technology solutions for healthcare professionals.

Gerardus Van Jeveren "Ger"Chief Executive OfficerJan PeetersChief Financial Officer
Dirk Van LerbergheCEO:CorilusMario HuygheCEO:Healthcare Solutions
More Company Profile & Key Executives for RCUS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil